| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Medical Biochemistry, Graduate School of Medicine,
2 Department of Anaesthesiology and Critical Care Medicine, Faculty of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
Lung alveolar epithelial cells are comprised of type I (ATI) and type II (ATII) cells. ATI cells are polarized, although they have very flat morphology. The identification of marker proteins for apical and basolateral membranes of ATI cells is important to investigate into the differentiation of ATI cells. In this paper, we characterized receptor for advanced glycation end-products (RAGE) as a marker for ATI cells. RAGE was localized on basolateral membranes of ATI cells in the immunoelectron microscopy and its expression was enhanced in a parallel manner to the differentiation of ATI cells in vivo and in primary cultures of ATII cells. RAGE and T1
, a well-known ATI marker protein, were targeted to basolateral and apical membranes, respectively, when expressed in polarized Madine Darby canine kidney cells. Moreover, RAGE was expressed in ATI cells after T1in vivo and in ex in vivo organ cultures. In conclusion, RAGE is a marker for basolateral membranes of well-differentiated ATI cells. ATI cells require some signal provided by the in vivo environment to express RAGE.
* Correspondence: E-mail: yuhammch{at}med.tmd.ac.jp
This article has been cited by other articles:
|
|
 |
|
  C S Calfee, L B Ware, M D Eisner, P E Parsons, B T Thompson, N Wickersham, M A Matthay, and the NHLBI ARDS Network Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury Thorax, December 1, 2008; 63(12): 1083 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Kemp, A. J. Thorley, J. Gorelik, M. J. Seckl, M. J. O'Hare, A. Arcaro, Y. Korchev, P. Goldstraw, and T. D. Tetley Immortalization of Human Alveolar Epithelial Cells to Investigate Nanoparticle Uptake Am. J. Respir. Cell Mol. Biol., November 1, 2008; 39(5): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Brincks, A. Katewa, T. A. Kucaba, T. S. Griffith, and K. L. Legge CD8 T Cells Utilize TRAIL to Control Influenza Virus Infection J. Immunol., October 1, 2008; 181(7): 4918 - 4925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hashimoto, F. Amaya, H. Matsuyama, H. Ueno, S. Kikuchi, M. Tanaka, Y. Watanabe, M. Ebina, A. Ishizaka, S. Tsukita, et al. Dysregulation of lung injury and repair in moesin-deficient mice treated with intratracheal bleomycin Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L566 - L574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Englert, L. E. Hanford, N. Kaminski, J. M. Tobolewski, R. J. Tan, C. L. Fattman, L. Ramsgaard, T. J. Richards, I. Loutaev, P. P. Nawroth, et al. A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis Am. J. Pathol., March 1, 2008; 172(3): 583 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. He, H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya The role of the receptor for advanced glycation end-products in lung fibrosis Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1427 - L1436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, K. Edeen, R. Manzer, Y. Chang, S. Wang, X. Chen, C.J. Funk, G. P. Cosgrove, X. Fang, and R. J. Mason Differentiated Human Alveolar Epithelial Cells and Reversibility of their Phenotype In Vitro Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kobayashi, H. Kubo, T. Suzuki, K. Ishizawa, M. Yamada, M. He, Y. Yamamoto, H. Yamamoto, H. Sasano, H. Sasaki, et al. Endogenous Secretory Receptor for Advanced Glycation End Products in Non-Small Cell Lung Carcinoma Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 184 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. DeBiase, K. Lane, S. Budinger, K. Ridge, M. Wilson, and J. C.R. Jones Laminin-311 (Laminin-6) Fiber Assembly by Type I-like Alveolar Cells J. Histochem. Cytochem., June 1, 2006; 54(6): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Uchida, M. Shirasawa, L. B. Ware, K. Kojima, Y. Hata, K. Makita, G. Mednick, Z. A. Matthay, and M. A. Matthay Receptor for Advanced Glycation End-Products Is a Marker of Type I Cell Injury in Acute Lung Injury Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1008 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, Z. Chen, N. R. Chintagari, M. Bhaskaran, N. Jin, T. Narasaraju, and L. Liu Alveolar type I cells protect rat lung epithelium from oxidative injury J. Physiol., May 1, 2006; 572(3): 625 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bartling, N. Demling, R.-E. Silber, and A. Simm Proliferative Stimulus of Lung Fibroblasts on Lung Cancer Cells Is Impaired by the Receptor for Advanced Glycation End-Products Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 83 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bartling, H.-S. Hofmann, B. Weigle, R.-E. Silber, and A. Simm Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma Carcinogenesis, February 1, 2005; 26(2): 293 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.C. McElroy and M. Kasper The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Eur. Respir. J., October 1, 2004; 24(4): 664 - 673. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |
